ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001

NCI To Pay 34 Percent Of Grants, At 155 Payline; $100 Million for Centers to Fund All Core Grants

January 29, 1988

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999